Humulin R
Liver Metastasis Colon Cancer
McGill University Health Centre/Research Institute of the McGill University Health CentreN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
13 Active assets in the Liver Metastasis Colon Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin Fudan University | Phase 4 | BBB |
FLUOROURACILUM Jun Huang | Phase 3 | BB |
Capecitabine Jun Huang | Phase 3 | BB |
Irinotecan Jun Huang | Phase 3 | BB |
Calcium folinate pentahydrate Jun Huang | Phase 3 | BB |
View all 15 →
Same molecule, other indications
Humulin R is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →